| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE
SI SK TR |
|
Designated Extension States: |
|
AL BA HR MK RS |
| (30) |
Priority: |
04.11.2005 US 734030 P 12.05.2006 US 747174 P 23.08.2006 US 823344 P 27.10.2006 US 553946
|
| (43) |
Date of publication of application: |
|
16.07.2008 Bulletin 2008/29 |
| (60) |
Divisional application: |
|
11171816.9 / 2404904 |
| (73) |
Proprietor: Panmira Pharmaceuticals, LLC |
|
San Diego, CA 92121 (US) |
|
| (72) |
Inventors: |
|
- HUTCHINSON, John, H.
La Jolla, CA 92037 (US)
- PRASIT, Petpiboon, Peppi
San Diego, CA 92121 (US)
- MORAN, Mark
Orinda, CA 94563 (US)
- EVANS, Jillian, F.
San Diego, California 92131 (US)
- STEARNS, Brian, Andrew
San Diego, CA 92104 (US)
- ROPPE, Jeffrey, Roger
Temecula, CA 92592 (US)
- LI, Yiwei
Lower Gwynedd, Pennsylvania 19002 (US)
- ZUNIC, Jasmine, Eleanor
San Diego, CA 92127 (US)
- ARRUDA, Jeannie, M.
San Diego, California 92104 (US)
- STOCK, Nicholas, Simon
San Diego, CA 92111 (US)
- HADDACH, Mustapha
San Diego, CA 92127 (US)
|
| (74) |
Representative: Price, Susanna Clare Hopley et al |
|
GlaxoSmithKline
Corporate Intellectual Property (CN925.1)
980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB) |
| (56) |
References cited: :
WO-A1-93/16069 US-A- 5 081 138 US-A1- 2004 198 800
|
WO-A2-2004/017917 US-A- 5 204 344
|
|
| |
|
|
- MILLER D.K. ET AL.: 'Identification and isolation of a membrane protein necessary
for leukotriene production' NATURE vol. 343, 18 January 1990, pages 278 - 281, XP003015233
- ROUZERT C.A. ET AL.: 'MK886, a potent and specific leukotriene biosynthesis inhibitor
blocks and reverses the membrane associated of 5-Lipooxygenase in Ionophore-challenged'
LEUKOCYTES 21 July 1989, XP008127006
|
|